University of Sydney, Nepean Blue Mountains Local Health District, Sydney, Australia.
Department of Physiology of Visceral Function, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Can J Cardiol. 2022 Apr;38(4):439-453. doi: 10.1016/j.cjca.2021.12.015. Epub 2022 Jan 1.
Electrical storm, characterized by repetitive ventricular tachycardia/ventricular fibrillation over a short period, is becoming more common with widespread use of implantable cardioverter defibrillator (ICD) therapy. Electrical storm, sometimes called "arrhythmic storm" or "ventricular tachycardia storm," is usually a medical emergency requiring hospitalization and expert management, and significantly affects short- and long-term outcomes. This syndrome typically occurs in patients with underlying structural heart disease (ischemic or nonischemic cardiomyopathy) or inherited channelopathies. Triggers for electrical storm should be sought but are often unidentifiable. Initial management is dictated by the hemodynamic status, whereas subsequent management typically involves ICD interrogation and reprogramming to reduce recurrent shocks, identification and management of triggers like electrolyte abnormalities, myocardial ischemia, or decompensated heart failure, and antiarrhythmic drug therapy or catheter ablation. Sympathetic nervous system activation is central to the initiation and maintenance of arrhythmic storm, so autonomic modulation is a cornerstone of management. Sympathetic inhibition can be achieved with medications (particularly β-adrenoreceptor blockers), deep sedation, or cardiac sympathetic denervation. More definitive management targets the underlying ventricular arrhythmia substrate to terminate and prevent recurrent arrhythmia. Arrhythmia targeting can be achieved with antiarrhythmic medications, catheter ablation, or more novel therapies, such as stereotactic radiation therapy, that target the arrhythmic substrate. Mechanistic studies point to adrenergic activation and other direct consequences of ICD shocks in promoting further arrhythmogenesis and hypocontractility. In this report, we review the pathophysiologic mechanisms, clinical features, prognosis, and therapeutic options for electrical storm. We also outline a clinical approach to this challenging and complex condition, along with its mechanistic basis.
电风暴是一种在短时间内反复发作室性心动过速/心室颤动的疾病,随着植入式心脏复律除颤器(ICD)治疗的广泛应用,其发病率越来越高。电风暴有时也被称为“心律失常风暴”或“室性心动过速风暴”,通常是一种需要住院和专家管理的医疗紧急情况,并且对短期和长期预后有显著影响。这种综合征通常发生在有潜在结构性心脏病(缺血性或非缺血性心肌病)或遗传性通道病的患者中。应寻找电风暴的触发因素,但通常无法确定。初始管理取决于血流动力学状态,而后续管理通常涉及 ICD 询问和重新编程以减少反复电击、识别和处理电解质异常、心肌缺血或失代偿性心力衰竭等触发因素,并进行抗心律失常药物治疗或导管消融。交感神经系统的激活是心律失常风暴发生和维持的核心,因此自主神经调节是管理的基石。可以通过药物(特别是β-肾上腺素能受体阻滞剂)、深度镇静或心脏交感神经去神经来实现交感神经抑制。更明确的管理目标是针对潜在的室性心律失常基质,以终止和预防心律失常的复发。可以通过抗心律失常药物、导管消融或更新型的治疗方法(如立体定向放射治疗)来实现心律失常靶向治疗,这些方法可以靶向心律失常基质。机制研究表明,去甲肾上腺素能激活和 ICD 电击的其他直接后果会促进进一步的心律失常发生和心肌收缩力降低。在本报告中,我们回顾了电风暴的病理生理机制、临床特征、预后和治疗选择。我们还概述了这种具有挑战性和复杂性疾病的临床方法及其机制基础。